Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Multi-omics landscape and clinical significance of a SMAD4 -driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3322/caac.21654
10.3322/caac.21654 · External reference
10.1001/jama.2021.13027
10.1001/jama.2021.13027 · External reference
10.1016/s0140-6736(20)30974-0
10.1016/s0140-6736(20)30974-0 · External reference
Maintenance olaparib for germline -mutated metastatic pancreatic cancer
10.1056/nejmoa1903387 · 2019 · External reference
10.1016/j.ccell.2020.08.004
10.1016/j.ccell.2020.08.004 · External reference
10.1016/s1470-2045(20)30532-5
10.1016/s1470-2045(20)30532-5 · External reference
10.7150/ijbs.23230
10.7150/ijbs.23230 · External reference
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer
10.1158/1078-0432.ccr-09-0227 · 2009 · External reference
10.1158/1078-0432.ccr-17-3435
10.1158/1078-0432.ccr-17-3435 · External reference
10.1038/sj.onc.1206751
10.1038/sj.onc.1206751 · External reference
Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
10.1186/s13045-020-00958-3 · 2020 · External reference
10.1158/2159-8290.cd-20-0519
10.1158/2159-8290.cd-20-0519 · External reference
10.1111/jcmm.16393
10.1111/jcmm.16393 · External reference
10.1093/bioinformatics/btq170
10.1093/bioinformatics/btq170 · External reference
10.1186/1471-2105-9-559
10.1186/1471-2105-9-559 · External reference
Clinical significance and inflammatory landscape of anovel recurrence-associated immune signature in stage II/III colorectal cancer
10.3389/fimmu.2021.702594 · 2021 · External reference
10.1016/j.celrep.2016.12.019
10.1016/j.celrep.2016.12.019 · External reference
10.1038/s41591-018-0136-1
10.1038/s41591-018-0136-1 · External reference
The identification and validation of two heterogenous subtypes and a risk signature based on ferroptosis in hepatocellular carcinoma
10.3389/fonc.2021.619242 · 2021 · External reference
10.1371/journal.pone.0001195
10.1371/journal.pone.0001195 · External reference
Hypoxia molecular characterization in hepatocellular carcinoma identifies one risk signature and two nomograms for clinical management
2021 · External reference
Tumor and microenvironment evolution during immunotherapy with nivolumab
10.1016/j.cell.2017.09.028 · 2017 · External reference
A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma
10.1186/s12967-020-02697-y · 2021 · External reference
Biomarkers of checkpoint inhibitor induced immune-related adverse events-a comprehensive review
10.3389/fonc.2020.585311 · 2020 · External reference
Bioinformatics-based identification of tumor microenvironment-related prognostic genes in pancreatic cancer
10.3389/fgene.2021.632803 · 2021 · External reference
Immunity-related gene signature identifies subtypes benefitting from adjuvant chemotherapy or potentially responding to PD1/PD-L1 blockage in pancreatic cancer
10.3389/fcell.2021.682261 · 2021 · External reference
Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
10.1186/s12935-021-02070-z · 2021 · External reference
10.1158/2326-6066.cir-18-0436
10.1158/2326-6066.cir-18-0436 · External reference
Construction and validation of an immune-related prognostic model based on TP53 status in colorectal cancer
10.3390/cancers11111722 · 2019 · External reference
10.1161/circulationaha.115.001593
10.1161/circulationaha.115.001593 · External reference
Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer
10.1007/s10555-021-09995-x · 2021 · External reference
10.1038/nrc3239
10.1038/nrc3239 · External reference
Molecular and metabolic subtypes correspondence for pancreatic ductal adenocarcinoma classification
10.3390/jcm9124128 · 2020 · External reference
10.1038/ng.3398
10.1038/ng.3398 · External reference
10.1158/1078-0432.ccr-19-1467
10.1158/1078-0432.ccr-19-1467 · External reference
10.1016/j.ebiom.2020.103068
10.1016/j.ebiom.2020.103068 · External reference
IL33 and mast cells-the key regulators of immune responses in gastrointestinal cancers?
10.3389/fimmu.2020.01389 · 2020 · External reference
